Log In
BCIQ
Print this Print this
 

Zavicefta, ceftazidime/avibactam (Avycaz) (CAZ-104)

Also known as: CAZ AVI, CAZ104 (formerly NXL104/ceftazidime)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionFixed-dose combination of ceftazidime, a third-generation cephalosporin, and avibactam, a broad-spectrum beta lactamase (LACTB) inhibitor
Molecular Target Beta lactamase (LACTB)
Mechanism of ActionBeta lactamase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,575.0M

$725.0M

$850.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/24/2016

$1,575.0M

$725.0M

$850.0M

Get a free BioCentury trial today